BKNG Stock Analysis: Booking Holdings | NASDAQ
Travel Services | NASDAQ, USA | Market Cap: 159.954m USD | 12M Return: -1.3% | US09857L1089 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.14B
EPS Trend: 34.6%
Qual. Beats: 0
Rev. Trend: 99.7%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Booking Holdings Inc. (NASDAQ: BKNG) is a leading online travel and restaurant reservation company that operates a portfolio of well-known consumer brands across the United States, the Netherlands, the United Kingdom, and other international markets. Its brands include Booking.com and Agoda for accommodation reservations, Priceline for discount travel and packaged reservations, KAYAK for meta-search travel comparison, and OpenTable for online restaurant reservations and management services. The company also generates revenue through travel-related insurance, payment facilitation, restaurant management services, and advertising, serving consumers, travel service providers, and restaurants. Originally founded in 1997 as The Priceline Group, the company rebranded to Booking Holdings Inc. in February 2018 and is headquartered in Norwalk, Connecticut.
Booking Holdings operates within the Consumer Discretionary sector (Hotels, Resorts & Cruise Lines sub-industry) and primarily follows an agency/merchant business model, earning commissions on travel bookings it facilitates rather than taking ownership of inventory. Its diversified portfolio of brands spans the full travel planning funnel, from price comparison and meta-search (KAYAK) to direct booking platforms and restaurant reservation services, providing multiple cross-selling and ancillary revenue opportunities.
- Room nights growth drives Booking.com gross bookings higher
- EU Digital Markets Act scrutiny threatens platform terms and fees
- Aggressive share buybacks accelerate earnings per share growth
| Net Income: 7.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.27 > 0.02 and ΔFCF/TA 8.33 > 1.0 |
| NWC/Revenue: 7.03% < 20% (prev 18.49%; Δ -11.46% < -1%) |
| CFO/TA 0.33 > 3% & CFO 9.86b > Net Income 7.21b |
| Net Debt (11.3b) to EBITDA (10.8b): 1.05 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (770.0m) vs 12m ago -5.58% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 93.57% > 50% (prev 81.56%; Δ 12.01% > 0%) |
| Interest Coverage Ratio: 9.19 > 6 (EBIT TTM 10.1b / Interest Expense TTM 1.10b) |
| A: 0.07 (Total Current Assets 23.1b - Total Current Liabilities 21.1b) / Total Assets 29.7b |
| B: 1.45 (Retained Earnings 43.0b / Total Assets 29.7b) |
| C: 0.34 (EBIT TTM 10.1b / Avg Total Assets 30.2b) |
| D: -0.27 (Book Value of Equity -10.8b / Total Liabilities 40.5b) |
| Altman-Z'' = 7.14 = AAA |
| DSRI: 0.88 (Receivables 4.34b/4.37b, Revenue 28.2b/25.0b) |
| GMI: 1.00 (GM 96.92% / 97.28%) |
| AQI: 0.91 (AQ_t 0.18 / AQ_t-1 0.19) |
| SGI: 1.13 (Revenue 28.2b / 25.0b) |
| TATA: -0.09 (NI 7.21b - CFO 9.86b) / TA 29.7b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of August 14, 2026, the stock is trading at USD 213.34 with a total of 3,667,657 shares traded. Over the past week, the price has changed by +2.87%, over one month by +21.35%, over three months by +37.96% and over the past year by -1.27%.
Current recommended Stop Loss: 202.60 (which is 5% or 1.4 ATR below the current price).
Booking Holdings has received a consensus analysts rating of 4.23. Therefore, it is recommended to buy BKNG.
- StrongBuy: 21
- Buy: 6
- Hold: 12
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 237.8 | 11.5% |
P/E Trailing = 23.8121
P/E Forward = 20.6186
P/S = 5.6639
P/B = 34.9536
P/EG = 0.9338
Revenue TTM = 28.2b USD
EBIT TTM = 10.1b USD
EBITDA TTM = 10.8b USD
Long Term Debt = 18.2b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 21.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 514.0m
Net Debt = 11.3b USD (calculated: Debt 21.2b - CCE 9.91b)
Enterprise Value = 171b USD (160b + Debt 21.2b - CCE 9.91b)
Interest Coverage Ratio = 9.19 (Ebit TTM 10.1b / Interest Expense TTM 1.10b)
EV/FCF = 21.04x (Enterprise Value 171b / FCF TTM 8.14b)
FCF Yield = 4.75% (FCF TTM 8.14b / Enterprise Value 171b)
FCF Margin = 28.82% (FCF TTM 8.14b / Revenue TTM 28.2b)
Net Margin = 25.53% (Net Income TTM 7.21b / Revenue TTM 28.2b)
Gross Margin = unknown ((Revenue TTM 28.2b - Cost of Revenue TTM 768.0m) / Revenue TTM)
Tobins Q-Ratio = 5.77 (Enterprise Value 171b / Total Assets 29.7b)
Interest Expense / Debt = 5.20% (Interest Expense 1.10b / Debt 21.2b)
Taxrate = 22.41% (2.08b / 9.29b)
NOPAT = 7.87b (EBIT 10.1b * (1 - 22.41%))
Current Ratio = 0.88 (Total Current Assets 23.1b / Total Current Liabilities 26.2b)
Debt / Equity = -1.97 (negative equity) (Debt 21.2b / totalStockholderEquity, last quarter -10.8b)
Debt / EBITDA = 1.05 (Net Debt 11.3b / EBITDA 10.8b)
Debt / FCF = 1.39 (Net Debt 11.3b / FCF TTM 8.14b)
Total Stockholder Equity = -7.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.88% (Net Income 7.21b / Total Assets 29.7b)
RoE = -96.70% (negative equity) (Net Income TTM 7.21b / Total Stockholder Equity -7.46b)
RoCE = 94.52% (EBIT 10.1b / Capital Employed (Equity -7.46b + L.T.Debt 18.2b))
RoIC = 85.50% (NOPAT 7.87b / Invested Capital 9.20b)
WACC = 8.28% (E(160b)/V(181b) * Re(8.84%) + D(21.2b)/V(181b) * Rd(5.20%) * (1-Tc(0.22)))
Discount Rate = 8.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.19 | Cagr: -5.17%
[DCF] Terminal Value 77.97% ; FCFF base≈7.23b ; Y1≈8.28b ; Y5≈12.2b
[DCF] Fair Price = 229.2 (EV 183b - Net Debt 11.3b = Equity 172b / Shares 751.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 34.65 | EPS CAGR: 23.92% | SUE: 0.03 | # QB: 0
Revenue Correlation: 99.74 | Revenue CAGR: 12.17% | SUE: 1.40 | # QB: 1
EPS current Quarter (2026-09-30): EPS=4.49 | Chg30d=-1.24% | Revisions=+0% | Analysts=25
EPS current Year (2026-12-31): EPS=10.45 | Chg30d=+0.07% | Revisions=+10% | GrowthEPS=+14.5% | GrowthRev=+8.7%
EPS next Year (2027-12-31): EPS=12.38 | Chg30d=+0.56% | Revisions=-44% | GrowthEPS=+18.5% | GrowthRev=+9.4%
[Analyst] Revisions Ratio: -14% (up=8, down=11)